Hemolytic Disease of the Newborn (HDN)
Author(s):
Shivani V. Mohite , Dhanushree M. Gosavi, Rutuja S. Devkar, Ravi P. Barkade
Keywords:
ALLOIMMUNIZATION, HAEMOLYSIS, IMMUNOPROPHYLAXIS.
Abstract
Hemolytic disease of the Newborn (HDN), also known as Erythroblastosis fetalis, is a hemolytic condition that generally affects rhesus-positive fetuses and babies born to rhesus-negative mothers. The pathophysiology of HDN begins with motherly antibodies attacking fetal red blood cells following alloimmunization due to rhesus or ABO incompatibility between the motherly and fetal blood. Preliminarily, HDN was known to cause death in 1 of all pregnancies, but with the arrival of immunoprophylactic therapies condition can be presently fairly well managed with smaller complications if diagnosed beforehand. To help the disease, before intravenous immunoglobulin (IVIG) should be given to pregnant Rh- women who haven't sensitized. The diagnosis and management of pregnant women with HDN is premised on laboratory and radiographic monitoring. This review covers the disorder’s etiology, pathophysiology, and administration, as well as treatment and their management to help in unborn investigation and confirmation-based medical practice.
Article Details
Unique Paper ID: 161954

Publication Volume & Issue: Volume 10, Issue 7

Page(s): 139 - 144
Article Preview & Download


Share This Article

Conference Alert

NCSST-2023

AICTE Sponsored National Conference on Smart Systems and Technologies

Last Date: 25th November 2023

SWEC- Management

LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT

Last Date: 7th November 2023

Go To Issue



Call For Paper

Volume 10 Issue 1

Last Date for paper submitting for March Issue is 25 June 2023

About Us

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org

Social Media

Google Verified Reviews